GlucoTrack short interest was 59.4% of the float on April 30th, according to new data we received from Benzinga. Short interest totaled 2,166,796 shares, which was an increase of 223.17% from April 15th.
It is estimated that it would take 1.0 days for short sellers to buy back their shares, with current trading volumes.
GlucoTrack Hedge Fund Activity
We have seen 4 institutional investors add shares of GlucoTrack stock to their portfolio, and 3 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- IKARIAN CAPITAL, LLC added 45,830 shares (+inf%) to their portfolio in Q4 2025, for an estimated $177,362
- BOOTHBAY FUND MANAGEMENT, LLC added 13,525 shares (+inf%) to their portfolio in Q4 2025, for an estimated $52,341
- ALERUS FINANCIAL NA removed 1,000 shares (-20.0%) from their portfolio in Q4 2025, for an estimated $3,870
- UBS GROUP AG added 583 shares (+489.9%) to their portfolio in Q1 2026, for an estimated $378
- MORGAN STANLEY removed 400 shares (-99.8%) from their portfolio in Q4 2025, for an estimated $1,548
- TOWER RESEARCH CAPITAL LLC (TRC) removed 381 shares (-47.3%) from their portfolio in Q4 2025, for an estimated $1,474
- BANK OF AMERICA CORP /DE/ added 21 shares (+300.0%) to their portfolio in Q4 2025, for an estimated $81
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
